PET/Computed Tomography and Precision Medicine: Gastric Cancer.

Journal Article (Journal Article;Review)

Gastric cancer is a disease with low survival rates and high morbidity, requiring accurate and prompt diagnosis and treatment. Although limited in the evaluation of the primary tumor as such, the metabolic information of primary tumors in an 18F-FDG PET/CT study can assist in surgical and treatment planning and differentiating gastric cancers. It detects nodal disease with good specificity and positive predictive value, thus enabling appropriate therapy for individual patients. It provides valuable information about distant metastases, altering therapy decisions. It has reasonably good performance in detecting recurrent disease and in the follow-up of patients.

Full Text

Duke Authors

Cited Authors

  • Marcus, C; Subramaniam, RM

Published Date

  • October 2017

Published In

Volume / Issue

  • 12 / 4

Start / End Page

  • 437 - 447

PubMed ID

  • 28867114

Electronic International Standard Serial Number (EISSN)

  • 1879-9809

Digital Object Identifier (DOI)

  • 10.1016/j.cpet.2017.05.004

Language

  • eng

Conference Location

  • United States